Full-Time

Pharmaceutical Sales Representative

Updated on 8/1/2026

Inizio Engage

Inizio Engage

501-1,000 employees

Provides integrated data insights for pharma

Compensation Overview

$52k - $96k/yr

Springfield, MA, USA + 1 more

More locations: Worcester, MA, USA

In Person

Must live within 25 miles of the territory border and be willing to travel.

Category
Sales & Account Management (1)
Required Skills
Microsoft Office
Sales
Inventory Management
CRM
Patient Education

Get referred to Inizio Engage

See people who can refer or advise you

Requirements
  • A Bachelor's Degree is required.
  • At least 2 years of relevant experience is required, including pharmaceutical sales, medical or medical device sales, professional sales or promotional activity, small business ownership or entrepreneurial experience, marketing, customer service, account management, relevant healthcare or scientific roles, educator experience, or full-time military experience.
  • Candidates must live within 25 miles of the border of the territory.
  • Candidates must have urgent care setting experience.
  • Candidates must be willing to travel.
  • Candidates must have a valid United States driver's license and a driving record that complies with company standards.
Responsibilities
  • Provide P1 support to physicians about COVID-19 risk factors, disease progression, and treatment options.
  • Educate identified targets to ensure customer preparedness for patient identification.
  • Build working relationships with customers through regular calls and ongoing contact as defined in the Field Pharmaceutical Sales Contracted Team Statement of Work.
  • Collaborate closely with customer-facing colleagues to align goals and coordinate efforts by channel and across field deployments.
  • Understand the customer and market landscape within assigned geographies, assess the business, prioritize opportunities, and develop and implement a plan of action to maximize local sales impact.
  • Engage healthcare professionals by probing and answering questions about drug-to-drug interaction management, product supply, and high-risk patients eligible for treatment.
  • Maintain expert knowledge of the product, patient education, consumer education, and factors influencing the market environment, using only approved promotional materials.
  • Maintain in-depth knowledge of the related disease state, market dynamics, quality programs, health information technology, care trends, and account-specific considerations to support meaningful customer dialogue.
  • Implement the strategic call plan to exceed goals for assigned geographies.
  • Analyze territory knowledge, previous customer interactions, and available data to maximize call effectiveness and tailor a sales approach for each target office.
  • Collaborate with colleagues to prioritize local and cross-channel opportunities and develop and implement strategies for targeted accounts.
  • Guide the retail pharmacy customer interface at the local level to support sales efforts.
  • Use interaction techniques including pre-call planning, opening, presentation focus, productive questions, issue identification, and call summary.
  • Customize sales-message delivery to align with known customer needs.
  • Share information on approved support resources.
  • Complete call reporting and inventory recording responsibilities according to current procedures and the scope of the Statement of Work.
  • Complete required study and certification time to learn medical, product, and policy information and maintain supplies, equipment, and records.
  • Prepare for and participate in required sales conferences and training classes at local or remote locations.
  • Complete all required compliance training within the timelines set by the client.

Inizio Engage turns scattered data into integrated insights and learning solutions for the pharmaceutical and biotechnology sectors. Its PROPENSITY4 data platform combines data from multiple sources to support decision making across customer needs, commercial operations, and strategic goals. The ecosystem includes Ashfield Excellence Academy, Axiom, Cormis, and Logicearth, which provide training, communications, and capability-building programs for pharma commercial and medical teams. By pairing data analytics with targeted training and talent development, the company helps patients, healthcare professionals, and pharmaceutical firms improve outcomes and gain competitive advantages.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Upper Dublin Township, Pennsylvania

Founded

N/A

Get referred to Inizio Engage

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Patient Access Services expands support across specialty, rare, and orphan diseases.[7]
  • Nazaré's AI Academy should increase client adoption of AI-enabled workflows.[8]
  • International footprint across multiple regions supports multinational pharma programs.[5][8]

What critics are saying

  • Pharma clients are shifting commercial operations in-house, compressing outsourced engagement demand.
  • Platform competitors bundle analytics, education, and field support into cheaper integrated contracts.
  • Regulatory and compliance failures can trigger immediate client termination in healthcare engagements.

What makes Inizio Engage unique

  • Global healthcare engagement partner with 30+ years in pharma commercialization.[1][2]
  • Propensity4 turns disparate data into integrated insight platforms for commercial decisions.[3]
  • Inizio Engage XD packages employee engagement, learning, events, film, digital, and behavioral science.[8]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Private Medical Insurance

Life Insurance

Pension Scheme

Hybrid Work Options

Paid Vacation

401(k) Retirement Plan

Company News

PMLiVE
Dec 11th, 2025
Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series

Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series. Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. We're pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum's latest "12 Questions" interview series. In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models. Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey. This content was provided by Inizio Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek(R) 2025 in Atlanta, experts from across Inizio reflected... Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making. Inizio today announced the launch of InConcert(TM), a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle. Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders. As the global hematology community prepares for the 67th ASH(R) Annual Meeting and Exposition, Inizio experts share their perspectives on what's driving the field forward - and how pharma companies... At Inizio Medical, we believe AI isn't replacing Medical Affairs - it's redefining what's possible. Our platform, iON.AI(TM), enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless... Discover how Inizio experts are shaping the future of obesity care - where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact. At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact - discover how this human-centered innovation is defining the... Inizio is leading the way in Intelligent Commercialization(TM) by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization. * 1 * 2 * 3 * 4 * 5 * 6 * 7 * 8 * 9 * 10 * 11 * 12 * 13 * 14 * 15 * 16 * 17 * 18 * 19 * 20 * 21 * 22 * 23 * 24 * 25 * 26 * 27 * 28 * 29 * 30 * 31 * 32 * 33 * 34 * 35 * 36 * 37 * 38 * 39 * 40 * 41 * 42 * 43 * 44 * 45 * 46 * 47 * 48 * 49 * 50

PMLiVE
Sep 24th, 2025
Inizio celebrates six finalist honors at the 2025 PM360 Trailblazer Awards

We're proud to announce that our teams across Inizio Evoke, Inizio Engage, and Inizio Medical have been named finalists in six prestigious categories at the 2025 PM360 Trailblazer Awards, which recognize excellence and innovation in healthcare marketing.

Bdaily
Sep 14th, 2025
Inizio names new chief executive

Inizio, a global commercialisation partner to health and life sciences companies, has appointed Ryan Quigley as chief executive.

Inizio Engage
Mar 5th, 2025
Inizio Engage choose Egg as Patient Support Program implementation partner in Italy.

After a review of potential Patient Support Program (PSP) partners in Italy, Inizio Engage has formed a collaboration with Egg, head quartered in Milan.

Haymarket Media
Feb 12th, 2025
The Escalator: Pfizer, Vertex Pharmaceuticals, Inizio and more

Inizio announced that Remco op den Kelder has been appointed to the president of Inizio Advisory and Jim Sage will become president of Inizio Engage.